Genotyping Market Size To Cross USD 67.60 Bn By 2032

The global genotyping market size accounted for US$ 16.9 Bn in 2022 and is projected to reach around USD 67.60 Bn by 2032, growing at a CAGR of 14.87% from 2023 to 2032.

Report Summary

The global genotyping market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the genotyping market across the globe.

A comprehensive estimate on the genotyping market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of genotyping during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2983

Genotyping Market Report Scope

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized genotyping market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read:  Cell-based Assays Market Size To Cross USD 42.32 Bn By 2032

Genotyping Market Players

The report includes the profiles of key genotyping market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

• Illumina Inc
• Thermo Fisher Scientific Inc.
• Qiagen Inc.
• F. Hoffmann-La Roche Ltd.
• Fluidigm Corporation
• Danaher Corporation
• Agilent Technologies
• Eurofins Scientific Inc.
• GE Healthcare Inc.
• Bio-Rad Laboratories Inc.
• Pacific Biosciences of California

Market Segmentation

By Product

• Instruments
• Sequencers & Amplifiers
• Analyzers
• Reagents & Kits
• Software and Services
• Genotyping Services

By Application

• Pharmacogenomics
• Diagnostics and Personalized Medicine
• Agricultural Biotechnology
• Animal Genetics
• Others

By Technology

• PCR
  • Real-time PCR
  • Digital PCR
• Capillary Electrophoresis
  • Amplified Fragment Length Polymorphism
  • Restriction Fragment Length Polymorphism
  • Single-Strand Conformation Polymorphism
• Microarrays
  • DNA Microarrays
  • Peptide Microarrays
  • Others
• Sequencing
  • Next Generation Sequencing
  • Pyro Sequencing
  • Sanger Sequencing
• Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-TOF) Mass Spectroscopy
• Others

By End Users

• Pharmaceutical And Biopharmaceutical Companies
• Diagnostics And Research Laboratories
• Academic Institutes
• Others

Regional Segmentation

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
• Latin America (Brazil and Rest of Latin America)
• Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

• Governmental bodies, and organizations creating economic policies
• National and international social welfare institutions
• Company websites, financial reports and SEC filings, broker and investor reports
• Related patent and regulatory databases
• Statistical databases and market reports
• Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

• Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
• In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Genotyping Market 

5.1. COVID-19 Landscape: Genotyping Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Genotyping Market, By Product

8.1. Genotyping Market, by Product, 2023-2032

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Sequencers & Amplifiers

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Analyzers

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Reagents & Kits

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Software and Services

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Genotyping Services

8.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Genotyping Market, By Application

9.1. Genotyping Market, by Application, 2023-2032

9.1.1. Pharmacogenomics

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Diagnostics and Personalized Medicine

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Agricultural Biotechnology

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Animal Genetics

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Genotyping Market, By March 

10.1. Genotyping Market, by March, 2023-2032

10.1.1. PCR

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Capillary Electrophoresis

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Microarrays

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Sequencing

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-TOF) Mass Spectroscopy

10.1.5.1. Market Revenue and Forecast (2020-2032)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Genotyping Market, By End Users 

11.1. Genotyping Market, by End Users, 2023-2032

11.1.1. Pharmaceutical And Biopharmaceutical Companies

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Diagnostics And Research Laboratories

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Academic Institutes

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Genotyping Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.3. Market Revenue and Forecast, by March (2020-2032)

12.1.4. Market Revenue and Forecast, by End Users (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.3. Market Revenue and Forecast, by March (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End Users (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.3. Market Revenue and Forecast, by March (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End Users (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.3. Market Revenue and Forecast, by March (2020-2032)

12.2.4. Market Revenue and Forecast, by End Users (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.3. Market Revenue and Forecast, by March (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End Users (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.3. Market Revenue and Forecast, by March (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End Users (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.3. Market Revenue and Forecast, by March (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End Users (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.3. Market Revenue and Forecast, by March (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End Users (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.3. Market Revenue and Forecast, by March (2020-2032)

12.3.4. Market Revenue and Forecast, by End Users (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.3. Market Revenue and Forecast, by March (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End Users (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.3. Market Revenue and Forecast, by March (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End Users (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.3. Market Revenue and Forecast, by March (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End Users (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.3. Market Revenue and Forecast, by March (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End Users (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.3. Market Revenue and Forecast, by March (2020-2032)

12.4.4. Market Revenue and Forecast, by End Users (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.3. Market Revenue and Forecast, by March (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End Users (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.3. Market Revenue and Forecast, by March (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End Users (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.3. Market Revenue and Forecast, by March (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End Users (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.3. Market Revenue and Forecast, by March (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End Users (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.3. Market Revenue and Forecast, by March (2020-2032)

12.5.4. Market Revenue and Forecast, by End Users (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.3. Market Revenue and Forecast, by March (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End Users (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.3. Market Revenue and Forecast, by March (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End Users (2020-2032)

Chapter 13. Company Profiles

13.1. Illumina Inc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Thermo Fisher Scientific Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Qiagen Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. F. Hoffmann-La Roche Ltd.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Fluidigm Corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Danaher Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Agilent Technologies

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Eurofins Scientific Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. GE Healthcare Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Bio-Rad Laboratories Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com